Original Article

You have full text access to this OnlineOpen article

Magnesium abnormalities of skeletal muscle in dermatomyositis and juvenile dermatomyositis

  1. Kenneth J. Niermann,
  2. Nancy J. Olsen*,
  3. Jane H. Park*

Article first published online: 5 FEB 2002

DOI: 10.1002/art.10109

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 46, Issue 2, pages 475–488, February 2002

Additional Information

How to Cite

Niermann, K. J., Olsen, N. J. and Park, J. H. (2002), Magnesium abnormalities of skeletal muscle in dermatomyositis and juvenile dermatomyositis. Arthritis & Rheumatism, 46: 475–488. doi: 10.1002/art.10109

Author Information

  1. Vanderbilt University School of Medicine, Nashville, Tennessee

*Department of Medicine, T-3219 MCN

Publication History

  1. Issue published online: 5 FEB 2002
  2. Article first published online: 5 FEB 2002
  3. Manuscript Accepted: 1 OCT 2001
  4. Manuscript Received: 20 JUN 2001

Funded by

  • Medical Student Research award from the American College of Rheumatology
  • Medical Scholar award from Vanderbilt University School of Medicine
  • Arthritis Foundation

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (185K)

REFERENCES

  • 1
    Park JH, Vansant JP, Kumar NG, Gibbs SJ, Curvin MS, Price RR, et al. Dermatomyositis: correlative MR imaging and P-31 MR spectroscopy for quantitative characterization of inflammatory disease. Radiology 1990; 177: 473–9.
  • 2
    Fraser DD, Frank JA, Dalakas M, Miller FW, Hicks JE, Plotz P. Magnetic resonance imaging in the idiopathic myopathies. J Rheumatol 1991; 18: 1693–9.
  • 3
    Newman ED, Kurland RJ. P-31 magnetic resonance spectroscopy in polymyositis and dermatomyositis: altered energy utilization during exercise. Arthritis Rheum 1992; 35: 199–203.
    Direct Link:
  • 4
    Ryder N, Park JH, Lawton A, Viner D, Hernanz-Schulman M, Olsen N. Magnetic resonance imaging (MRI) and P-31 MR spectroscopy (MRS) for evaluation of juvenile dermatomyositis (JDM) [abstract]. Arthritis Rheum 1994; 37 Suppl 9: S243.
  • 5
    Park JH, Niermann KJ, Ryder NM, Nelson AE, Das A, Lawton AR, et al. Muscle abnormalities in juvenile dermatomyositis patients: P-31 magnetic resonance spectroscopy studies. Arthritis Rheum 2000; 43: 2359–67.
    Direct Link:
  • 6
    Park JH, Olsen NJ, King L Jr, Vital T, Buse R, Kari S, et al. Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis. Arthritis Rheum 1995; 38: 68–77.
    Direct Link:
  • 7
    Park JH, Vital TL, Ryder NM, Hernanz-Schulman M, Partain CL, Price RR, et al. Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis. Arthritis Rheum 1994; 37: 736–46.
    Direct Link:
  • 8
    Phothimat P, Park JH, Olsen NJ, Carr BN, King LE Jr. Abnormalities in levels of free and ATP-bound magnesium (Mg2+) in muscles of dermatomyositis patients [abstract]. Arthritis Rheum 1996; 39 Suppl 9: S97.
  • 9
    Park JH, Olsen NJ, Phothimat P, Carr BN, King LE. Free and ATP-bound magnesium levels are decreased in muscle disease: dermatomyositis [abstract]. Int Soc Magn Reson Med 1997; 5: 163.
  • 10
    Niermann KJ, Park JH, Olsen NJ. Abnormalities in levels of total and ATP-bound magnesium (Mg2+) in muscles of juvenile dermatomyositis patients [abstract]. Arthritis Rheum 2000; 43 Suppl 9: S194.
  • 11
    Cronin RE, Knochel JP. Magnesium deficiency. Adv Int Med 1983; 28: 509–33.
  • 12
    Ryschon TW, Rosenstein DL, Rubinow DR, Niemela JE, Elin RJ, Balaban RS. Relationship between skeletal muscle intracellular ionized magnesium and measurements of blood magnesium. J Lab Clin Med 1996; 127: 207–13.
  • 13
    Cohn M, Hughes TR. Nuclear magnetic resonance spectra of adenosine di- and triphosphate. J Biol Chem 1962; 237: 176–81.
  • 14
    Gupta R, Benovic JL, Rose ZB. The determination of the free magnesium level in the human red blood cell by P-31 NMR. J Biol Chem 1978; 252: 6172–6.
  • 15
    Welch KMA, Ramadan NM. Mitochondria, magnesium and migraine. J Neurol Sci 1995; 134: 9–14.
  • 16
    Taylor JS, Vigneron DB, Murphy-Boesch J, Nelson SJ, Kessler HB, et al. Free magnesium levels in normal human brain and brain tumors: P-31 chemical-shift imaging measurements at 1.5T. Proc Natl Acad Sci U S A 1991; 88: 6810–4
  • 17
    Oberhaensli RD, Galloway GJ, Taylor DJ, Bore PJ, Radda GK. Assessment of human liver metabolism by phosphorus-31 magnetic resonance spectroscopy. Br J Radiol 1986; 59: 695–9.
  • 18
    Ward KM, Rajan SS, Wysong M, Radulovic D, Clauw DJ. Phosphorus nuclear magnetic resonance spectroscopy: in vivo magnesium measurements in the skeletal muscle of normal subjects. Magn Reson Med 1996; 36: 475–80.
    Direct Link:
  • 19
    Weiss M, Lasserre B. Should magnesium therapy be considered for the treatment of coronary heart disease? I. A critical appraisal of current facts and hypotheses. Magnes Res 1994; 7: 135–44.
  • 20
    Resnick LM, Altura BT, Gupta RK, Laragh JH, Alderman MH, Altura BM. Intracellular and extracellular magnesium depletion in type 2 diabetes mellitus. Diabetologia 1993; 36: 767–70.
  • 21
    Clauw DJ, Ward K, Wilson B, Katz P, Rajan SS. Magnesium deficiency in the eosinophilia–myalgia syndrome: report of clinical and biochemical improvement with repletion. Arthritis Rheum 1994; 37: 1331–4.
    Direct Link:
  • 22
    Fudman EJ, Schnitzer TJ. Dermatomyositis without creatine kinase elevation. Am J Med 1986; 80: 329–32.
  • 23
    Chao CP, Blaiss MS, Higgins CG. A 4-year-old girl with a chronic pruritic rash. Ann Allergy 1993; 71: 217–22.
  • 24
    Harris RC, Hultman E, Nordesjo LO. Glycogen, glycolytic intermediates and high energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest. Scand J Clin Lab Invest 1974; 33: 385–94.
  • 25
    Mosher TJ, Williams GD, Doumen C, LaNoue KF, Smith MB. Error in the calibration of the MgATP chemical-shift limit: effects on the determination of free magnesium by P-31 NMR spectroscopy. Magn Reson Med 1992; 24: 163–9.
    Direct Link:
  • 26
    Irish AB, Thompson CH, Kemp GJ, Taylor DJ, Radda GK. Intracellular free magnesium concentrations in skeletal muscle in chronic uraemia. Nephron 1997; 76: 20–5.
  • 27
    Arnold DL, Matthews PM, Radda GK. Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of P-31 NMR. Magn Reson Med 1984; 1: 307–15.
    Direct Link:
  • 28
    Taylor DJ, Bore PJ, Gadian DG, Radda GK. Bioenergetics of intact human muscle: a 31P nuclear magnet resonance study. Mol Biol Med 1983; 1: 77–94.
  • 29
    Veloso D, Guynn RW, Oskarsson M, Veech RL. Concentrations for free and bound magnesium in rat tissues. J Biol Chem 1973; 248: 4811–9.
  • 30
    Rosenstein DL, Ryschon TW, Niemela JE, Elin RJ, Balaban RS, Rubinow DR. Skeletal muscle intracellular ionized magnesium measured by P-31 NMR spectroscopy across the menstrual cycle. J Am Coll Nutrition 1995; 14: 486–90.
  • 31
    Kushmerick MJ, Dillon PF, Meyer RA, Brown TR, Krisanda JM, Sweeney HL. P-31 NMR spectroscopy, chemical analysis, and free Mg2+ of rabbit bladder and uterine smooth muscle. J Biol Chem 1986; 261: 14420–9.
  • 32
    Gupta RK, Moore RD. P-31 NMR studies of intracellular free Mg2+ in intact frog skeletal muscle. J Biol Chem 1980; 255: 3987–93.
  • 33
    Roth K, Weiner MW. Determination of cytosolic ADP and AMP concentrations and the free energy of ATP hydrolysis in human muscle and brain tissues with 31P NMR spectroscopy. Magn Reson Med 1991; 22: 505–11.
    Direct Link:
  • 34
    Blazev R, Lamb GD. Low [ATP] and elevated [Mg2+] reduce depolarized-induced Ca2+ release in rat skinned skeletal muscle fibres. J Physiol (Lond) 1999; 520: 203–15.
    Direct Link:
  • 35
    Resnick LM, Gupta RK, Gruenspan H, Laragh JH. Intracellular free magnesium in hypertension: relation to peripheral insulin resistance. J Hypertens Suppl 1988; 6: S199–201.
  • 36
    Tominga S, Curnish RR, Belardinelli L, Rubio E, Berne RM. Adenosine release during early and sustained exercise of canine skeletal muscle. Am J Physiol 1980; 238: H156–63.
  • 37
    Costa F, Heusinkveld J, Ballog R, Davis S, Biaggioni I. Estimation of skeletal muscle interstitial adenosine during forearm dynamic exercise in humans. Hypertension 2000; 35: 1124–8.
  • 38
    Iotti S, Frassineti C, Alderighi L, Sabatini A, Vacca A, Barbiroli B. In vivo 31P MRS assessment of cytosolic [Mg2+] in the human skeletal muscle in different metabolic conditions. Magn Reson Imaging 2000; 18: 607–14.
  • 39
    Iotti S, Tarducci R, Gottardi G, Barbiroli B. Cytosolic free [Mg2+] in the human calf muscle in different metabolic conditions: in vivo 31P MRS and computer simulation [abstract]. Int Soc Magn Reson Med 1999; 7: 1540.
  • 40
    Barbiroli B, Iotti S, Cortelli P, Martinelli P, Lodi R, Carelli V, et al. Low brain intracellular free magnesium in mitochondrial cytopathies. J Cereb Blood Flow Metab 1999; 19: 528–32.
  • 41
    Butler AM. Diabetic coma. N Engl J Med 1950; 234: 648–56.
  • 42
    Sjogren A, Floren CH, Nilsson A. Magnesium deficiency in IDDM related to levels of glycosylated hemoglobin. Diabetes 1986; 35: 459–63.
  • 43
    Shils M. Magnesium in health and disease. Ann Rev Nutr 1988; 8: 420–60.
  • 44
    Paolisso G, Scheen A, Cozzolino D, Di Maro G, Varricchio M, D'Onofrio F, et al. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly non-insulin dependent (type II) diabetic patients. J Clin Endocrinol Metab 1994; 78: 1510–4.
  • 45
    Gullestad L, Dolva LO, Soyland E, Manger AT, Falch D, Kjekshus J. Oral magnesium supplementation improves metabolic variables and muscle strength in alcoholics. Alcohol Clin Exp Res 1992; 16: 986–90.
    Direct Link:
  • 46
    Widman L, Wester PO, Stegmayr BK, Wirell M. The dose-dependent reduction in blood pressure through administration of magnesium: a double blind placebo controlled cross-over study. Am J Hypertens 1993; 6: 41–5.
  • 47
    Witteman JC, Grobbee DE, Derkx FH, Bouillon R, deBruijn AM, Hofman A. Reduction in blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. Am J Clin Nutr 1994; 60: 129–35.
  • 48
    Brilla LR, Haley TF. Effect of magnesium supplementation on strength training in humans. J Am Coll Nutr 1992; 11: 326–9.
  • 49
    Golf SW, Bohmer D, Nowacki PE. Is magnesium a limiting factor in competitive exercise? A summary of relevant scientific data. In: GolfS, DralleD, VecchietL, editors. Magnesium 1993. London: John Libbey; 1993. p. 209–20.
  • 50
    Pachman LM. Juvenile dermatomyositis. Pediatr Clin North Am 1986; 33: 1097–117.
View Full Article (HTML) Get PDF (185K)